Pacific Biosciences of California, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for PACB, updated each market day.
PACB AI Sentiment
AI sees no strong directional signal for Pacific Biosciences of California, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Sector
Exchange
Market Cap
$407,697,694
Cap Tier
Employees
485
Headquarters
MENLO PARK, CA
Listed Since
Oct. 27, 2010
Website
PACB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PACB Volatility
Pacific Biosciences of California, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
